Delivery Order SPE2DB24D1034-SPE2DB25FVYM7

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,911.25, is for the delivery of 4567202646 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication. The contract has an ultimate completion date of February 10, 2025 and was awarded on February 7, 2025. The contract is not designated as a set-aside....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567360089 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has an ultimate completion date of February 25, 2025 and a ceiling value of $1,703.76. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $1,451.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with 4567239635 - NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a specialty pharmaceutical product, with a performance period ending on February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.69, is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566998409 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, with a ceiling value of $2,154.42 and an ultimate completion date of January 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,250.53, is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $3,492.30 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567342237 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty pharmaceutical product, with a period of performance through February 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a pharmaceutical product. The contract has a ceiling value of $3,492.30 and a period of performance through February 14, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, valued at $1,753.62, is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,602.78 firm fixed-price delivery order is for the supply of 4567317362 NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML medical products. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FVYM7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,428.44, is for the supply of 4566433656 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/20/25, 1:47 PM